Lenalidomide Combined to Azacitidine in Intermediate-2 or High Risk MDS With Del 5q
Clinical trial NCT01088373 · COMPLETED
Trial details
- NCT number
- NCT01088373
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-25
- Primary completion
- 2016-07-25
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.